CID 92035044

Crosultaine e 30

Structural Information

Molecular Formula
C30H61N2O5S
SMILES
CCCCCCCC/C=C\CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(CS(=O)(=O)O)O
InChI
InChI=1S/C30H60N2O5S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-24-30(34)31-25-23-26-32(2,3)27-29(33)28-38(35,36)37/h11-12,29,33H,4-10,13-28H2,1-3H3,(H-,31,34,35,36,37)/p+1/b12-11-
InChIKey
ONYHQNURMVNRJZ-QXMHVHEDSA-O
Compound name
3-[[(Z)-docos-13-enoyl]amino]propyl-(2-hydroxy-3-sulfopropyl)-dimethylazanium
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

0
References

1189
Patents

561.4301 Da
Monoisotopic Mass

7.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 562.43738 252.0
[M+Na]+ 584.41932 255.8
[M-H]- 560.42282 245.7
[M+NH4]+ 579.46392 252.0
[M+K]+ 600.39326 254.2
[M+H-H2O]+ 544.42736 241.4
[M+HCOO]- 606.42830 258.9
[M+CH3COO]- 620.44395 248.7
[M+Na-2H]- 582.40477 235.5
[M]+ 561.42955 248.7
[M]- 561.43065 248.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe